134 related articles for article (PubMed ID: 16439878)
1. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.
Barry PM; Zetola N; Keruly JC; Moore RD; Gebo KA; Lucas GM
AIDS; 2006 Feb; 20(3):437-44. PubMed ID: 16439878
[TBL] [Abstract][Full Text] [Related]
2. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.
Grau I; Ardanuy C; Liñares J; Podzamczer D; Schulze MH; Pallares R
HIV Med; 2009 Sep; 10(8):488-95. PubMed ID: 19459987
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
4. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
[TBL] [Abstract][Full Text] [Related]
5. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.
Yin Z; Rice BD; Waight P; Miller E; George R; Brown AE; Smith RD; Slack M; Delpech VC
AIDS; 2012 Jan; 26(1):87-94. PubMed ID: 22008657
[TBL] [Abstract][Full Text] [Related]
6. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.
Harboe ZB; Larsen MV; Ladelund S; Kronborg G; Konradsen HB; Gerstoft J; Larsen CS; Pedersen C; Pedersen G; Obel N; Benfield T
Clin Infect Dis; 2014 Oct; 59(8):1168-76. PubMed ID: 25038114
[TBL] [Abstract][Full Text] [Related]
9. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study.
Peñaranda M; Falco V; Payeras A; Jordano Q; Curran A; Pareja A; Samperiz G; Dalmau D; Ribera E; Riera M
Clin Infect Dis; 2007 Oct; 45(7):e82-7. PubMed ID: 17806042
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.
Dworkin MS; Ward JW; Hanson DL; Jones JL; Kaplan JE;
Clin Infect Dis; 2001 Mar; 32(5):794-800. PubMed ID: 11229848
[TBL] [Abstract][Full Text] [Related]
12. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
[TBL] [Abstract][Full Text] [Related]
13. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.
Lebouché B; Yazdanpanah Y; Gérard Y; Sissoko D; Ajana F; Alcaraz I; Boitte P; Cadoré B; Mouton Y
HIV Med; 2006 Apr; 7(3):140-5. PubMed ID: 16494627
[TBL] [Abstract][Full Text] [Related]
14. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States.
Fry AM; Facklam RR; Whitney CG; Plikaytis BD; Schuchat A
J Infect Dis; 2003 Sep; 188(5):643-52. PubMed ID: 12934179
[TBL] [Abstract][Full Text] [Related]
15. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
[TBL] [Abstract][Full Text] [Related]
16. Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006.
Ndiaye B; Ould-Kaci K; Salleron J; Bataille P; Bonnevie F; Choisy P; Cochonat K; Fontier C; Guerroumi H; Ajana F; Chaud P; Yazdanpanah Y
Antivir Ther; 2009; 14(4):567-75. PubMed ID: 19578242
[TBL] [Abstract][Full Text] [Related]
17. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
18. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
[TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
20. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
Jordano Q; Falcó V; Almirante B; Planes AM; del Valle O; Ribera E; Len O; Pigrau C; Pahissa A
Clin Infect Dis; 2004 Jun; 38(11):1623-8. PubMed ID: 15156452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
